Impact Factor
3.45
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.70
233 total citations
h5-index
19
h5 depth signal
Cited share
73.6%
39 of 53
Total citations
233
Citation footprint
Metric signal
4.41
External metric anchor
Self-citation
0.9%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
41
China
16
United Kingdom
15
Italy
10
Netherlands
7
Citing Fields of Research
Oncology
78
Viral Identification & Phylogenetics
31
Virology
15
Lymphomas
12
Immunology
12
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
124
Articles tracked across the journal lifetime
Indexed publication set
53
39 cited publications
Last 12 months
20
1.8 publications/month
Open access share
100.0%
20 OA publications in the last year
Leading citing country
United States
41 citing publications
Leading citing field
Oncology
78 citing publications
Latest tracked publication
1 September 2026
10 recent records available
Coverage & Indexing History
v11, 2021-
v11, 2021-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Viral Identification & Phylogenetics
Virology
Hepatitis
Broad Categories
Neoplasms
Virology
Oncology
MeSH Descriptors
Medical Oncology
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.tvr.2026.200350
Open DOI
IL-33/IL1RL1 (ST2) signalling drives immune suppression in squamous intraepithelial hyperplasia
02
DOI 10.1016/j.tvr.2026.200351
Open DOI
HPV integration as a triage tool for HPV-positive women in cervical cancer screening
03
04
DOI 10.1016/j.tvr.2026.200347
Open DOI
HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL
05
DOI 10.1016/j.tvr.2026.200348
Open DOI
HPV8-E6 drives coordinated transcriptional and epigenetic reprogramming of keratinocytes
06
DOI 10.1016/j.tvr.2026.200346
Open DOI
Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat
07
DOI 10.1016/s2666-6790(26)00007-8
Open DOI
Editorial board member
08
DOI 10.1016/j.tvr.2026.200342
Open DOI
Oncolytic virus hijacks GOT1 and pyrimidinosomes to fuel pyrimidine synthesis for replication in tumor cells
09
10
DOI 10.1016/j.tvr.2026.200340
Open DOI